Fredrik Müller

发表

Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival.

S. Frøland, P. Aukrust, C. Haug, 1994, The Journal of infectious diseases.

Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses

S. Frøland, T. Ueland, A. Svardal, 2000, European journal of clinical investigation.

Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.

S. Frøland, F. Müller, P. Aukrust, 1996, Blood.

IL‐10 in HIV infection: increasing serum IL‐10 levels with disease progression—down‐regulatory effect of potent anti‐retroviral therapy

S. Frøland, F. Müller, P. Aukrust, 1999, Clinical and experimental immunology.

Elevated circulating levels of C-C chemokines in patients with congestive heart failure.

J. Kjekshus, S. Frøland, T. Ueland, 1998, Circulation.

Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection.

S. Frøland, P. Aukrust, P. Holme, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.

E. Aandahl, K. Taskén, S. Frøland, 1999, Journal of immunology.

Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection.

F. Müller, Fredrik Müller, 1992, Free radical biology & medicine.

Elevated plasma levels of reduced homocysteine in common variable immunodeficiency — a marker of enhanced oxidative stress

P. Ueland, R. Berge, S. Frøland, 1997, European journal of clinical investigation.

Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.

P. Ueland, R. Berge, S. Frøland, 1995, Blood.

Reduced oxidative burst responses in monocytes and monocyte‐derived macrophages from HIV‐infected subjects

H. Rollag, S. FrØLand, F. Müller, 1990, Clinical and experimental immunology.

Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection

S. Frøland, P. Aukrust, K. Bendtzen, 2000, Clinical and experimental immunology.

Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)

S. Frøland, T. Ueland, J. Damås, 2012, Clinical and experimental immunology.

The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.

H. Rollag, S. Frøland, F. Müller, 2000, The Journal of infectious diseases.

Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion.

S. Frøland, F. Müller, P. Aukrust, 1998, Blood.

Administration of intravenous immunoglobulin (IVIG) in vivo—down‐regulatory effects on the IL‐1 system

I. Nordøy, Müller, Aukrust, 1999, Clinical and experimental immunology.

Cytomegalovirus Infection Induces Production of Human Interleukin-10 in Macrophages

H. Rollag, S. Frøland, M. Degré, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection.

P. Ueland, R. Berge, S. Frøland, 1996, The American journal of clinical nutrition.

Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency

F. Müller, S. FrØLand, P. Aukkust, 1994, Clinical and experimental immunology.

Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events.

S. Frøland, F. Müller, P. Aukrust, 1998, Blood.

Virological and immunological effects of antioxidant treatment in patients with HIV infection

R. Berge, S. Frøland, F. Müller, 2000, European journal of clinical investigation.

Reduced serum level of transforming growth factor-beta in patients with IgA deficiency.

S. Frøland, P. Aukrust, D. E. Nilssen, 1995, Clinical immunology and immunopathology.

Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy.

J. Bollerslev, S. Frøland, T. Ueland, 1999, The Journal of clinical endocrinology and metabolism.

Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART.

E. Aandahl, K. Taskén, S. Frøland, 1999, AIDS.